These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 23121656)
21. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Pardo A; Bartolí R; Lorenzo-Zúñiga V; Planas R; Viñado B; Riba J; Cabré E; Santos J; Luque T; Ausina V; Gassull MA Hepatology; 2000 Apr; 31(4):858-63. PubMed ID: 10733540 [TBL] [Abstract][Full Text] [Related]
22. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature. Pijls KE; Jonkers DM; Elamin EE; Masclee AA; Koek GH Liver Int; 2013 Nov; 33(10):1457-69. PubMed ID: 23879434 [TBL] [Abstract][Full Text] [Related]
23. [Current problems in the prevention and treatment of infections in patients with cirrhosis]. Bellot P; Jara Pérez López N; Martínez Moreno B; Such J Gastroenterol Hepatol; 2010 Dec; 33(10):729-40. PubMed ID: 20444525 [TBL] [Abstract][Full Text] [Related]
24. Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis. Francés R; González-Navajas JM; Zapater P; Muñoz C; Caño R; Pascual S; Santana F; Márquez D; Pérez-Mateo M; Such J Clin Exp Immunol; 2007 Nov; 150(2):230-7. PubMed ID: 17822441 [TBL] [Abstract][Full Text] [Related]
25. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Bauer TM; Steinbrückner B; Brinkmann FE; Ditzen AK; Schwacha H; Aponte JJ; Pelz K; Kist M; Blum HE Am J Gastroenterol; 2001 Oct; 96(10):2962-7. PubMed ID: 11693333 [TBL] [Abstract][Full Text] [Related]
26. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls. Chander Roland B; Garcia-Tsao G; Ciarleglio MM; Deng Y; Sheth A J Clin Gastroenterol; 2013; 47(10):888-93. PubMed ID: 23632359 [TBL] [Abstract][Full Text] [Related]
27. [Bacterial endotoxinemia and risk of hemorrhage from oesophageal varicose veins in patients with liver cirrhosis]. Garbuzenko DV; Mikurov AA; Smirnov DM Klin Med (Mosk); 2012; 90(7):48-51. PubMed ID: 23019976 [TBL] [Abstract][Full Text] [Related]
28. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis. Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624 [TBL] [Abstract][Full Text] [Related]
29. Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis. Giannelli V; Di Gregorio V; Iebba V; Giusto M; Schippa S; Merli M; Thalheimer U World J Gastroenterol; 2014 Dec; 20(45):16795-810. PubMed ID: 25492994 [TBL] [Abstract][Full Text] [Related]
30. Influence of malnutrition on the prevalence of bacterial translocation and spontaneous bacterial peritonitis in experimental cirrhosis in rats. Casafont F; Sánchez E; Martín L; Agüero J; Romero FP Hepatology; 1997 Jun; 25(6):1334-7. PubMed ID: 9185748 [TBL] [Abstract][Full Text] [Related]
31. Inflammatory status in human hepatic cirrhosis. Martínez-Esparza M; Tristán-Manzano M; Ruiz-Alcaraz AJ; García-Peñarrubia P World J Gastroenterol; 2015 Nov; 21(41):11522-41. PubMed ID: 26556984 [TBL] [Abstract][Full Text] [Related]
32. [Relationships between ascitic bacterial DNA and plasma endotoxin, gut flora and intestinal permeability in cirrhotic patients]. Jiang CY; Wang BE; Wang JC Zhonghua Gan Zang Bing Za Zhi; 2008 Aug; 16(8):594-8. PubMed ID: 18752746 [TBL] [Abstract][Full Text] [Related]
34. Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats. Zhang S; Wang W; Ren W; Dai Q; He B; Zhou K Chin Med J (Engl); 2003 May; 116(5):767-71. PubMed ID: 12875698 [TBL] [Abstract][Full Text] [Related]
35. Microbiome and bacterial translocation in cirrhosis. Gómez-Hurtado I; Such J; Francés R Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042 [TBL] [Abstract][Full Text] [Related]
36. [Antibiotics can ameliorate circulatory complications of liver cirrhosis]. Madsen BS; Schaffalitzky de Muckadell OB Ugeskr Laeger; 2011 Aug; 173(35):2127-30. PubMed ID: 21884664 [TBL] [Abstract][Full Text] [Related]
37. Systemic inflammatory response syndrome in patients with liver cirrhosis. Abdel-Khalek EE; El-Fakhry A; Helaly M; Hamed M; Elbaz O Arab J Gastroenterol; 2011 Dec; 12(4):173-7. PubMed ID: 22305496 [TBL] [Abstract][Full Text] [Related]
38. Detection of ascitic fluid infections in patients with liver cirrhosis and ascites. Mostafa MS; El-Seidi EA; Kassem AM; Shemis MA; Saber M; Michael MN Arab J Gastroenterol; 2011 Mar; 12(1):20-4. PubMed ID: 21429450 [TBL] [Abstract][Full Text] [Related]
39. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine. Kerckhoffs AP; Visser MR; Samsom M; van der Rest ME; de Vogel J; Harmsen W; Akkermans LM J Clin Gastroenterol; 2008; 42(10):1095-102. PubMed ID: 18936644 [TBL] [Abstract][Full Text] [Related]
40. [Bacterial translocation and its surgical implications]. Sileri P; Sica GS; Rastellini C; Dicuonzo G; Gaspari AL; Cicalese L G Chir; 1999 Oct; 20(10):440-4. PubMed ID: 10555416 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]